PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 130 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,300,000 | -59.2% | 102,278 | +24.5% | 0.00% | -66.7% |
Q1 2019 | $3,187,000 | +641.2% | 82,166 | +288.5% | 0.00% | – |
Q4 2018 | $430,000 | -87.9% | 21,148 | -72.8% | 0.00% | -100.0% |
Q3 2018 | $3,566,000 | +10.8% | 77,783 | +43.0% | 0.00% | 0.0% |
Q2 2018 | $3,217,000 | +7.5% | 54,389 | +23.7% | 0.00% | 0.0% |
Q1 2018 | $2,992,000 | -20.0% | 43,965 | +16.2% | 0.00% | -25.0% |
Q4 2017 | $3,740,000 | -39.9% | 37,840 | -27.2% | 0.00% | -33.3% |
Q3 2017 | $6,225,000 | +61.5% | 51,984 | +17.9% | 0.01% | +50.0% |
Q2 2017 | $3,855,000 | +284.0% | 44,102 | +63.4% | 0.00% | +300.0% |
Q1 2017 | $1,004,000 | -96.6% | 26,987 | -97.2% | 0.00% | -96.8% |
Q4 2016 | $29,178,000 | -33.2% | 950,419 | +45.8% | 0.03% | -35.4% |
Q3 2016 | $43,695,000 | +12982.3% | 651,675 | +14590.6% | 0.05% | – |
Q3 2015 | $334,000 | -35.6% | 4,436 | -0.2% | 0.00% | -100.0% |
Q2 2015 | $519,000 | -84.1% | 4,446 | -67.9% | 0.00% | -75.0% |
Q1 2015 | $3,269,000 | +24.1% | 13,846 | -0.5% | 0.00% | +33.3% |
Q4 2014 | $2,634,000 | -21.6% | 13,916 | -1.2% | 0.00% | -25.0% |
Q3 2014 | $3,361,000 | +182.9% | 14,088 | -21.7% | 0.00% | +300.0% |
Q2 2014 | $1,188,000 | -39.9% | 17,994 | -5.1% | 0.00% | -50.0% |
Q1 2014 | $1,976,000 | +10.9% | 18,970 | +10.3% | 0.00% | 0.0% |
Q4 2013 | $1,781,000 | – | 17,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |